CRL · 10-Q · 2026Q2 · Full report
Capital Return Program
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 58 · Surprise 42 · No source text
The board authorized a $1.0 billion stock repurchase program on October 29, 2025. During the six months ended June 27, 2026, Charles River repurchased 1.7 million shares for $300.0 million under the program, leaving $700.0 million authorized at June 27, 2026. The company also acquired $20.7 million of stock through equity-award tax-withholding netting, representing 0.1 million shares. Total treasury stock purchases shown in financing activities were $323.9 million, including the $300.0 million program purchases and $20.7 million withholding-related purchases.
Key facts
- On October 29, 2025, the Board approved a stock repurchase program of $1.0 billion; during the six months ended June 27, 2026 Charles River repurchased 1.7 million shares for $300.0 million under the program, leaving $700.0 million remaining on the authorized program as of June 27, 2026. source
- During the six months ended June 27, 2026, cash used for treasury stock purchases was $300.0 million associated with the stock repurchase program and $20.7 million due to netting of common stock upon vesting of awards. source
- During the six months ended June 27, 2026, Charles River acquired 0.1 million shares for $20.7 million through netting of common stock upon vesting of stock-based awards to satisfy statutory tax withholding requirements. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -4.3% | During the six months ended June 27, 2026, cash used for treasury stock purchases was $300.0 million associated with the stock repurchase… |
| cash | negative | realized | -4.0% | On October 29, 2025, the Board approved a stock repurchase program of $1.0 billion; during the six months ended June 27, 2026 Charles… |